此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Development of a Digital Acceptance and Commitment Therapy Intervention for Suicide Prevention in Adults Through Co-design

2026年7月23日 更新者:The Hong Kong Polytechnic University
Suicide is a major public health concern and there is a need for accessible and scalable interventions to support individuals experiencing suicidal thoughts. The aim of this study is to develop a digital Acceptance and Commitment Therapy (ACT) intervention for suicide prevention in Chinese adults through co-design. The study will involve literature review, interviews, and co-design activities to identify user needs, preferences, and contextual factors, and to develop the intervention. Following intervention development, a pilot study will be conducted to evaluate the feasibility, usability, acceptability, and user engagement of the intervention. Findings from this study will inform further refinement of the intervention and future evaluation studies.

研究概览

研究类型

介入性

注册 (估计的)

80

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习联系方式

学习地点

      • Hong Kong、中国
        • The Hong Kong Polytechnic University
        • 接触:
          • Bryant Hui
          • 电话号码:+85227667744

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

  • 成人
  • 年长者

接受健康志愿者

不

描述

  • Inclusion Criteria Lived experience participants

    1. Aged 18 years or older;
    2. Have experienced suicidal thoughts and/or behaviors;
    3. Able to read and communicate in Chinese; Professionals
    1. Aged 18 years or older;
    2. Professionals with experience relevant to suicide prevention, Acceptance and Commitment Therapy (ACT), digital mental health, or related fields;
  • Exclusion Criteria

    1. Unable to provide informed consent or participate in study activities;
    2. Currently experiencing acute suicide risk requiring immediate intervention;
    3. Severe cognitive impairment or active psychotic symptoms that would prevent participation.

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:预防
  • 分配:不适用
  • 介入模型:单组作业
  • 屏蔽:无(打开标签)

武器和干预

参与者组/臂
干预/治疗
实验性的:Digital ACT Intervention
The Digital ACT Intervention will be co-designed with stakeholders and informed by co-design activities. The intervention aims to support adults experiencing suicidal thoughts through a digital platform.
A co-designed digital Acceptance and Commitment Therapy (ACT) intervention for suicide prevention

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Intervention completion rate
大体时间:End of the intervention (approximately 2 weeks)
The intervention completion rate will be assessed as the percentage of participants who complete the digital intervention, based on intervention usage records.
End of the intervention (approximately 2 weeks)
Retention rate
大体时间:End of the 1-month follow-up
The participant retention rate will be assessed as the percentage of participants who complete the post-intervention assessment and the follow-up assessment.
End of the 1-month follow-up
Acceptability outcome
大体时间:End of the intervention (approximately 2 weeks)
Acceptability of the intervention will be assessed using participant-reported ratings and feedback regarding satisfaction and overall experience with the intervention.
End of the intervention (approximately 2 weeks)
Usability outcome
大体时间:End of the intervention (approximately 2 weeks)
Usability will be assessed using the System Usability Scale (SUS), a 10-item self-report questionnaire. Total scores range from 0 to 100, with higher scores indicating better usability of the intervention.
End of the intervention (approximately 2 weeks)

次要结果测量

结果测量
措施说明
大体时间
Suicide ideation
大体时间:Baseline, end of the 2-week intervention, and 1-month follow-up
Suicidal ideation will be assessed using the Beck Scale for Suicide Ideation (BSSI). Each item is rated on a 3-point scale ranging from 0 to 2, with higher scores indicating greater suicidal ideation.
Baseline, end of the 2-week intervention, and 1-month follow-up
Psychological flexibility and inflexibility
大体时间:Baseline, end of the 2-week intervention, and 1-month follow-up
Psychological flexibility and inflexibility will be assessed using the Multidimensional Psychological Flexibility Inventory-24 (MPFI-24). Each item is rated on a 6-point scale ranging from 1 to 6. Higher scores on the flexibility and inflexibility subscales indicate greater psychological flexibility and psychological inflexibility, respectively.
Baseline, end of the 2-week intervention, and 1-month follow-up
Psychological Distress
大体时间:Baseline, end of the 2-week intervention, and 1-month follow-up
Psychological distress will be assessed using the Depression Anxiety Stress Scales (DASS). Each item is rated on a 4-point scale ranging from 0 to 3, with higher scores indicating greater psychological distress.
Baseline, end of the 2-week intervention, and 1-month follow-up
Mental well-being
大体时间:Baseline, end of the 2-week intervention, and 1-month follow-up
Mental well-being will be assessed using the Mental Health Continuum-Short Form (MHC-SF). Each item is rated on a 6-point scale ranging from 0 to 5, with higher scores indicating greater mental well-being.
Baseline, end of the 2-week intervention, and 1-month follow-up

其他结果措施

结果测量
措施说明
大体时间
Qualitative Feedback and Design Recommendations
大体时间:Through study completion, an average of 6 months
Qualitative feedback related to user needs, preferences, barriers, facilitators, cultural considerations, and recommendations for intervention refinement will be identified from co-design activities and feedback sessions.
Through study completion, an average of 6 months
Cultural Relevance
大体时间:Through study completion, an average of 6 months
Cultural relevance of the intervention will be assessed through participant feedback regarding the appropriateness, relevance, and cultural fit of the intervention content and delivery.
Through study completion, an average of 6 months

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:Tao Zhang、The Hong Kong Polytechnic University

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (估计的)

2026年7月15日

初级完成 (估计的)

2026年10月31日

研究完成 (估计的)

2026年12月30日

研究注册日期

首次提交

2026年7月9日

首先提交符合 QC 标准的

2026年7月23日

首次发布 (实际的)

2026年7月29日

研究记录更新

最后更新发布 (实际的)

2026年7月29日

上次提交的符合 QC 标准的更新

2026年7月23日

最后验证

2026年6月1日

更多信息

与本研究相关的术语

其他相关的 MeSH 术语

其他研究编号

  • HSEARS20260122008-1

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅